go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

SYNCRO-MED Orthopädische Erzeugnisse GmbH

Organization type
RDM medtech
Region
Upper Austria
Topic
assistive products for persons with disability
Details

Chateau Natal GmbH

Organization type
RDM medtech
Region
Vienna
Topic
Covid-19 devices
Details

MASURATION GmbH

Organization type
RDM medtech
Region
Tyrol
Cluster
Life Sciences Tyrol
Details

REPULS Lichtmedizintechnik GmbH

Organization type
RDM medtech
Region
Vienna
Cluster
LISAvienna
Topic
electromechanical medical devices
Details

Contact



Contact: